When.com Web Search

  1. Ads

    related to: treatment for osteoporosis in women

Search results

  1. Results From The WOW.Com Content Network
  2. Osteoporosis - Wikipedia

    en.wikipedia.org/wiki/Osteoporosis

    Frequency. 15% (50 year olds), 70% (over 80 year olds) [7] Osteoporosis is a systemic skeletal disorder characterized by low bone mass, micro-architectural deterioration of bone tissue leading to more porous bone, and consequent increase in fracture risk. It is the most common reason for a broken bone among the elderly. [3]

  3. Raloxifene - Wikipedia

    en.wikipedia.org/wiki/Raloxifene

    Raloxifene is used for the treatment and prevention of osteoporosis in postmenopausal women. [10] It is used at a dosage of 60 mg/day for both the prevention and treatment of osteoporosis. [11] In the case of either osteoporosis prevention or treatment, supplemental calcium and vitamin D should be added to the diet if daily intake is inadequate ...

  4. Osteopenia - Wikipedia

    en.wikipedia.org/wiki/Osteopenia

    Osteopenia, known as " low bone mass " or " low bone density ", is a condition in which bone mineral density is low. [ 1 ] Because their bones are weaker, people with osteopenia may have a higher risk of fractures, and some people may go on to develop osteoporosis. [ 2 ] In 2010, 43 million older adults in the US had osteopenia. [ 3 ]

  5. Senile osteoporosis - Wikipedia

    en.wikipedia.org/wiki/Senile_osteoporosis

    While senile osteoporosis is categorized as an involuntary, Type II, and primary osteoporosis, which affects both men and women over the age of 70 years. It is accompanied by vitamin D deficiency, body's failure to absorb calcium, and increased parathyroid hormone. [2][3] Research over the years has shown that senile osteoporosis is the product ...

  6. Selective estrogen receptor modulator - Wikipedia

    en.wikipedia.org/wiki/Selective_estrogen...

    Raloxifene is used for the prevention and treatment of postmenopausal osteoporosis and breast cancer prevention in high-risk postmenopausal women with osteoporosis. [5] Preclinical and clinical reports suggest that it is considerably less potent than estrogen for the treatment of osteoporosis.

  7. Denosumab - Wikipedia

    en.wikipedia.org/wiki/Denosumab

    Denosumab. Denosumab, sold under the brand names Prolia and Xgeva among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone. [9][10] Denosumab is contraindicated in people with low blood calcium levels. The most common side effects are joint ...

  1. Ads

    related to: treatment for osteoporosis in women